Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 2
1986 3
1987 3
1988 3
1989 4
1990 4
1991 4
1993 9
1994 7
1995 8
1996 8
1997 11
1998 11
1999 12
2000 5
2001 5
2002 11
2003 6
2004 26
2005 20
2006 23
2007 46
2008 51
2009 64
2010 58
2011 85
2012 107
2013 123
2014 145
2015 177
2016 210
2017 202
2018 224
2019 276
2020 302
2021 396
2022 471
2023 419
2024 530
2025 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,645 results

Results by year

Filters applied: . Clear all
Page 1
Expert consensus on difficult airway assessment.
Xia M, Ma W, Zuo M, Deng X, Xue F, Battaglini D, Aggarwal V, Varrassi G, Cerny V, Di Giacinto I, Cataldo R, Ma D, Yamamoto T, Rekatsina M, De Cassai A, Carsetti A, Chang MG, Seet E, Davis DP, Irwin MG, Huang Y, Jiang H. Xia M, et al. Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):545-566. doi: 10.21037/hbsn-23-46. Epub 2023 May 19. Hepatobiliary Surg Nutr. 2023. PMID: 37600997 Free PMC article. Review.
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.
Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S, Ma J, Wang A, Xu X, Shahane SA, Xia M, Woo J, Mensah GA, Wang Z, Ferrer M, Gabrielson E, Li Z, Rastinejad F, Shen M, Boxer MB, Biswal S. Singh A, et al. Among authors: xia m. ACS Chem Biol. 2016 Nov 18;11(11):3214-3225. doi: 10.1021/acschembio.6b00651. Epub 2016 Oct 17. ACS Chem Biol. 2016. PMID: 27552339 Free PMC article.
Functional connectome through the human life span.
Sun L, Zhao T, Liang X, Xia M, Li Q, Liao X, Gong G, Wang Q, Pang C, Yu Q, Bi Y, Chen P, Chen R, Chen Y, Chen T, Cheng J, Cheng Y, Cui Z, Dai Z, Deng Y, Ding Y, Dong Q, Duan D, Gao JH, Gong Q, Han Y, Han Z, Huang CC, Huang R, Huo R, Li L, Lin CP, Lin Q, Liu B, Liu C, Liu N, Liu Y, Liu Y, Lu J, Ma L, Men W, Qin S, Qiu J, Qiu S, Si T, Tan S, Tang Y, Tao S, Wang D, Wang F, Wang J, Wang P, Wang X, Wang Y, Wei D, Wu Y, Xie P, Xu X, Xu Y, Xu Z, Yang L, Yuan H, Zeng Z, Zhang H, Zhang X, Zhao G, Zheng Y, Zhong S; Alzheimer’s Disease Neuroimaging Initiative; Cam-CAN; Developing Human Connectome Project; DIDA-MDD Working Group; MCADI; NSPN; He Y. Sun L, et al. Among authors: xia m. bioRxiv [Preprint]. 2024 Jun 10:2023.09.12.557193. doi: 10.1101/2023.09.12.557193. bioRxiv. 2024. PMID: 37745373 Free PMC article. Preprint.
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial.
Qiao Q, Han C, Ye S, Li J, Shao G, Bai Y, Xu A, Sun M, Wang W, Wu J, Huang M, Song L, Huang L, Liu T, Liu W, Wang ZM, Li B, Xia M, Bai L. Qiao Q, et al. Among authors: xia m. Front Immunol. 2023 Oct 24;14:1238667. doi: 10.3389/fimmu.2023.1238667. eCollection 2023. Front Immunol. 2023. PMID: 37942328 Free PMC article. Clinical Trial.
A General and Convenient Peptide Self-Assembling Mechanism for Developing Supramolecular Versatile Nanomaterials Based on The Biosynthetic Hybrid Amyloid-Resilin Protein.
Wu J, Zhou L, Peng H, Wang Z, Wang Z, Keasling JD, Liu S, Zhou G, Ding S, Wang Q, Wang X, Chen X, Lang Y, Xia M, Guan X, Dong M, Zhou J, Chen J. Wu J, et al. Among authors: xia m. Adv Mater. 2024 Jan;36(4):e2304364. doi: 10.1002/adma.202304364. Epub 2023 Dec 3. Adv Mater. 2024. PMID: 37885340
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function.
Isshiki Y, Chen X, Teater M, Karagiannidis I, Nam H, Cai W, Meydan C, Xia M, Shen H, Gutierrez J, Easwar Kumar V, Carrasco SE, Ouseph MM, Yamshon S, Martin P, Griess O, Shema E, Porazzi P, Ruella M, Brentjens RJ, Inghirami G, Zappasodi R, Chadburn A, Melnick AM, Béguelin W. Isshiki Y, et al. Among authors: xia m. Cancer Cell. 2025 Jan 13;43(1):49-68.e9. doi: 10.1016/j.ccell.2024.11.006. Epub 2024 Dec 5. Cancer Cell. 2025. PMID: 39642889
3,645 results